Concerns Over Kratom Usage and Regulation in the U.S.

Concerns Over Kratom Usage and Regulation in the U.S.

Kratom, a substance affecting opioid receptors, is widely accessible in the United States. Originating from a tree in Southeast Asia, locals have used kratom’s leaves for tea and their stimulating effects for generations.

The kratom market in the U.S. is significant, generating billions in revenue. Products containing kratom can be bought online and in numerous retail outlets, including gas stations. Proponents claim it aids in overcoming opioid addiction and is a mild stimulant. Many high-ranking government officials support its legal status in most states, despite health experts cautioning against its potential for addiction and overdose.

Dr. Andrew Kolodny, affiliated with Brandeis University’s Opioid Policy Research Collaborative, likens kratom’s impacts to oxycodone, heroin, and fentanyl. The Centers for Disease Control and Prevention reported over 5,000 overdose deaths involving kratom from 2020 to 2024. The American Kratom Association, a consumer advocacy group, promotes kratom as a safe, natural herbal supplement.

Several families shared their stories with 60 Minutes, explaining how their sons sought health benefits from kratom but tragically passed away. Susan Eppard recounted her son Matthew’s belief that kratom was akin to coffee. Similarly, Patti Wheeler’s son Wyatt and Wendy Chamberlain’s son Joe used kratom to mitigate their alcohol dependency and for energy, respectively. Matthew and Joe’s deaths directly linked to mitragynine, kratom’s main compound, reflect growing concerns.

Justin Brower, a toxicologist at NMS Labs near Philadelphia, noted a substantial rise in kratom-related fatalities in recent years. He observed that the number of such deaths had increased about tenfold since 2014.

The Food and Drug Administration advises against using kratom due to risks like liver damage, seizures, and addiction. Given the potential dangers of kratom-derived products, the federal government initially planned to regulate certain substances, including 7-OH. However, in a recent decision, the Department of Health and Human Services increased the permissible levels of 7-OH in products.

This change bewildered health officials like former FDA Commissioner Dr. Marty Makary. Investigation revealed significant lobbying by the American Kratom Association to influence decisions regarding kratom’s legality and regulation. Dr. Kolodny highlighted similarities to past lobbying efforts by Purdue Pharma for OxyContin, emphasizing the downplaying of risks and overstatement of potential benefits.

When approached, HHS declined an interview but stated that political donations and outside pressure did not affect their decision regarding 7-OH. The American Kratom Association distinguished between natural kratom and products they deem dangerous due to chemical manipulation.

Susan Eppard expressed disbelief that kratom remains available for purchase. She frequently speaks to store employees, informing them of her son’s story and the potential dangers they might unknowingly contribute to by selling kratom.

Leave a Reply

Your email address will not be published. Required fields are marked *